Cited by 8Bacterial Genetics and BiotechnologyStreptococcal Infections and TreatmentsCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection

Open access

Published version of a preprint

Abstract

Abstract In Streptococcus pyogenes , the type II fatty acid (FA) synthesis pathway FASII is feedback- controlled by the FabT repressor bound to an acyl-Acyl carrier protein. Despite FabT defects being linked to reduced virulence in animal models, spontaneous fabT mutants arise in vivo . To resolve this paradox, we characterized the conditions and mechanisms that require FabT activity, and those that promote fabT mutant emergence. The primary fabT mutant defect is energy dissipation: specific nutrients are consumed, but the mutant fails to grow on human tissue, cells, or cell filtrates where nutrients are limited. These features explain the FabT requirement during infection. Conversely, fabT mutants exhibited a marked growth advantage over the wild-type in biotopes rich in saturated FAs. fabT mutants emerge in this context, where continued FASII activity prevented environmental FA incorporation. An ex vivo muscle model demonstrated that wild-type S. pyogenes was inhibited, while fabT mutant growth was stimulated, but conditional to FASII activity. Our findings elucidate the rationale for emerging fabT mutants that improve survival in lipid-rich biotopes, but lead to a genetic impasse for infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-52637-3

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 45

  1. Jerga, A. & Rock, C. O. Acyl-Acyl carrier protein regulates transcription of fatty acid biosynthetic genes via the FabT repressor in Streptococcus pneumoniae. J. Biol. Chem. 284, 15364–15368 (2009). · DOI
  2. Lambert, C. et al. Acyl-AcpB, a FabT corepressor in Streptococcus pyogenes. J. Bacteriol. 205, e0027423 (2023). · DOI
  3. Lambert, C., Poyart, C., Gruss, A. & Fouet, A. FabT, a bacterial transcriptional repressor that limits futile fatty acid biosynthesis. Microbiol. Mol. Biol. Rev. 86, e0002922 (2022). · DOI
  4. Zou, Q., Zhu, L. & Cronan, J. E. The Enterococcus faecalis FabT transcription factor regulates fatty acid synthesis in response to exogenous fatty acids. Front. Microbiol. 13, 877582 (2022). · DOI
  5. Eraso, J. M. et al. Genomic landscape of intrahost variation in group A Streptococcus: repeated and abundant mutational inactivation of the fabT gene encoding a regulator of fatty acid synthesis. Infect. Immun. 84, 3268–3281 (2016). · DOI
  6. Lu, Y. J. & Rock, C. O. Transcriptional regulation of fatty acid biosynthesis in Streptococcus pneumoniae. Mol. Microbiol. 59, 551–566 (2006). · DOI
  7. Eckhardt, T. H., Skotnicka, D., Kok, J. & Kuipers, O. P. Transcriptional regulation of fatty acid biosynthesis in Lactococcus lactis. J. Bacteriol. 195, 1081–1089 (2013). · DOI
  8. Faustoferri, R. C. et al. Regulation of fatty acid biosynthesis by the global regulator CcpA and the local regulator FabT in Streptococcus mutans. Mol. Oral. Microbiol 30, 128–146 (2015). · DOI
  9. Zhang, J. et al. Inactivation of transcriptional regulator FabT influences colony phase variation of Streptococcus pneumoniae. mBio 12, e0130421 (2021). · DOI
  10. Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005). · DOI
  11. Tatsuno, I. et al. Relevance of spontaneous fabT mutations to a streptococcal toxic shock syndrome to non-streptococcal toxic shock syndrome transition in the novel-type Streptococcus pyogenes isolates that lost a salRK. APMIS 124, 414–424 (2016). · DOI
  12. Longo, M. et al. Complete genome sequence of Streptococcus pyogenes emm28 clinical isolate M28PF1, responsible for a puerperal fever. Genome Announc. 3, https://doi.org/10.1128/genomeA.00750-15 (2015). · DOI
  13. Lambert, C. et al. A Streptococcus pyogenes DegV protein regulates the membrane lipid content and limits the formation of extracellular vesicles. PLoS ONE 18, e0284402 (2023). · DOI
  14. Zuo, G. et al. Structural insights into repression of the Pneumococcal fatty acid synthesis pathway by repressor FabT and co-repressor acyl-ACP. FEBS Lett. 593, 2730–2741 (2019). · DOI
  15. Haines, T. H. & Dencher, N. A. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett. 528, 35–39 (2002). · DOI
  16. Port, G. C., Vega, L. A., Nylander, A. B. & Caparon, M. G. Streptococcus pyogenes polymyxin B-resistant mutants display enhanced ExPortal integrity. J. Bacteriol. 196, 2563–2577 (2014). · DOI
  17. Teuber, M. & Miller, I. R. Selective binding of polymyxin B to negatively charged lipid monolayers. Biochim Biophys. Acta 467, 280–289 (1977). · DOI
  18. Rosinski-Chupin, I., Sauvage, E., Fouet, A., Poyart, C. & Glaser, P. Conserved and specific features of Streptococcus pyogenes and Streptococcus agalactiae transcriptional landscapes. BMC Genomics 20, 236 (2019). · DOI
  19. Zhu, L. et al. Contribution of Secreted NADase and Streptolysin O to the Pathogenesis of Epidemic Serotype M1 Streptococcus pyogenes Infections. Am. J. Pathol. 187, 605–613 (2017). · DOI
  20. Green, N. M. et al. Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192, 760–770 (2005). · DOI
  21. Plainvert, C. et al. Invasive group A streptococcal infections in adults, France (2006–2010). Clin. Microbiol Infect. 18, 702–710 (2012). · DOI
  22. Weckel, A. et al. Streptococcus pyogenes infects human endometrium by limiting the innate immune response. J. Clin. Invest. 131, https://doi.org/10.1172/JCI130746 (2021). · DOI
  23. Vadia, S. et al. Fatty acid availability sets cell envelope capacity and dictates microbial cell size. Curr. Biol. 27, 1757–1767 e1755 (2017). · DOI
  24. Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358–361 (2006). · DOI
  25. Thormar, H. & Hilmarsson, H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem. Phys. Lipids 150, 1–11 (2007). · DOI
  26. Ni Raghallaigh, S., Bender, K., Lacey, N., Brennan, L. & Powell, F. C. The fatty acid profile of the skin surface lipid layer in papulopustular rosacea. Br. J. Dermatol. 166, 279–287 (2012). · DOI · Paper page
  27. Tsujii, H., Matsuoka, Y., Obata, R., Hossain, M. S. & Takagi, Y. Fatty acid composition of lipids in day 7-13 blastocysts, serum and uterine fluid of rabbits. Reprod. Med. Biol. 8, 107–112 (2009). · DOI
  28. Young, H. J., Jenkins, N. T., Zhao, Q. & McCully, K. K. Measurement of intramuscular fat by muscle echo intensity. Muscle Nerve 52, 963–971 (2015). · DOI
  29. Brinster, S. et al. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458, 83–86 (2009). · DOI
  30. Kenanian, G. et al. Permissive fatty acid incorporation promotes Staphylococcal adaptation to FASII antibiotics in host environments. Cell Rep. 29, 3974–3982 e3974 (2019). · DOI
  31. Hays, C. et al. Type II fatty acid synthesis pathway and cyclopropane ring formation are dispensable during Enterococcus faecalis systemic infection. J. Bacteriol. 203, e0022121 (2021). · DOI
  32. Weckel, A. et al. The N-terminal domain of the R28 protein promotes emm28 group A Streptococcus adhesion to host cells via direct binding to three integrins. J. Biol. Chem. 293, 16006–16018 (2018). · DOI
  33. Six, A. et al. Srr2, a multifaceted adhesin expressed by ST-17 hypervirulent Group B Streptococcus involved in binding to both fibrinogen and plasminogen. Mol. Microbiol 97, 1209–1222 (2015). · DOI
  34. Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021). · DOI
  35. Abreu, S., Solgadi, A. & Chaminade, P. Optimization of normal phase chromatographic conditions for lipid analysis and comparison of associated detection techniques. J. Chromatogr. A 1514, 54–71 (2017). · DOI
  36. Thedieck, K. et al. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol. Microbiol. 62, 1325–1339 (2006). · DOI
  37. Moulin, M. et al. Sex-specific cardiac cardiolipin remodelling after doxorubicin treatment. Biol. Sex. Differ. 6, 20 (2015). · DOI
  38. Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463–470 (2016). · DOI
  39. Anders, S. et al. Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nat. Protoc. 8, 1765–1786 (2013). · DOI
  40. Varet, H., Brillet-Gueguen, L., Coppee, J. Y. & Dillies, M. A. SARTools: A DESeq2- and EdgeR-Based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS ONE 11, e0157022 (2016). · DOI
  41. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289–300 (1995). · DOI · Paper page
  42. Lex, A., Gehlenborg, N., Strobelt, H., Vuillemot, R. & Pfister, H. UpSet: visualization of intersecting sets. IEEE Trans. Vis. Comput Graph 20, 1983–1992 (2014). · DOI
  43. Conway, J. R., Lex, A. & Gehlenborg, N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics 33, 2938–2940 (2017). · DOI · Paper page
  44. Plainvert, C. et al. A novel CovS variant harbored by a colonization strain reduces Streptococcus pyogenes virulence. J. Bacteriol. e0003923, https://doi.org/10.1128/jb.00039-23 (2023). · DOI
  45. Marcellin, L. et al. Immune modifications in fetal membranes overlying the cervix precede parturition in humans. J. Immunol. 198, 1345–1356 (2017). · DOI

Metadata

Authors
Lambert, C., Gaillard, M., Wongdontree, P., Bachmann, C., Hautcoeur, A., Gloux, K., Guilbert, T., Méhats, C., Prost, B., Solgadi, A., Abreu, S., Andrieu, M., Poyart, C., Gruss, A., & Fouet, A.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • AgroParisTech (FR)
  • Université Paris-Saclay (FR)
Corresponding author
Gruss, Alexandra
Venue
Nature Communications
Published
2024-10-04
Volume
15
Issue
1
Pages
8593-8593
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4403135616
Cited by
8
References
3
Citations by year
2026: 5 · 2025: 1 · 2024: 1
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Agence Nationale de la Recherche (ANR-22-AAMR-0007, ANR‐10_INBS‐04, ANR-10, ANR-16-CE15-0013)
  • Fondation pour la Recherche Médicale (DBF20161136769, FDT202106012831)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
Streptococcus pyogenes, fatty acid synthesis regulation, acyl-acyl carrier protein, bacterial virulence, saturated fatty acids, energy dissipation, bacterial fitness
MeSH terms
Animals, Bacterial Proteins, Fatty Acids, Female, Humans, Mutation, Repressor Proteins, Streptococcal Infections, Streptococcus pyogenes, Virulence, Gene Expression Regulation, Bacterial, Mice, Fatty Acid Synthase, Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review